Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Vesalio Announces FDA 510(k) Clearance of pVasc NET, a Next-Generation Peripheral ...

13 August 2026 · By · Wire by Fusion42

Published

13 August 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at prnewswire.com →

◆ Verified

Fusion42 · 13 August 2026 · Fusion42 review

Vesalio has received FDA 510(k) clearance for its pVasc NET, a next-generation peripheral mechanical thrombectomy device featuring an integrated distal filter.

This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it.

◆ ◆ The Wire takeaway

You can now compete in the US market with a cleared peripheral thrombectomy device that reduces embolic risks. This opens immediate US commercial opportunities but also demands rapid compliance with FDA post-clearance standards.

◆ Coverage

3 sources · 13 Aug 2026

◆ Related on Wire

◆ Topics

Medtechfda-clearancemechanical-thrombectomymedtechmedical-deviceperipheral-vascular